XML 86 R4.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Statements of Comprehensive Loss - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Revenues:        
Net product revenue $ 1,617 $ 291 $ 2,710 $ 291
Royalties and other revenue 30 26 67 49
Total revenues 1,647 317 2,777 340
Operating expenses:        
Cost of sales 166 8 197 8
Research and development, including stock-based compensation of $1,679, $1,302, $3,273, and $2,505, respectively 17,643 14,541 32,015 26,567
Selling, general and administrative, including stock-based compensation of $3,180, $2,513, $5,888, and $4,725, respectively 39,192 30,008 71,252 49,147
Total operating expenses 57,001 44,557 103,464 75,722
Loss from operations (55,354) (44,240) (100,687) (75,382)
Interest and other expense  (2,211) (1,960) (7,159) (3,781)
Interest income and other, net 4,136 1,296 6,020 2,325
Net loss $ (53,429) $ (44,904) $ (101,826) $ (76,838)
Net loss per common share, basic (usd per share) $ (0.17) $ (0.22) $ (0.37) $ (0.39)
Net loss per common share, diluted (usd per share) $ (0.17) $ (0.22) $ (0.37) $ (0.39)
Shares used in computing net loss per common share, basic 310,836 204,783 278,113 196,942
Shares used in computing net loss per common share, diluted 310,836 204,783 278,113 196,942
Other comprehensive loss:        
Unrealized (loss) gain on investments $ (143) $ 63 $ (224) $ 328
Comprehensive loss $ (53,572) $ (44,841) $ (102,050) $ (76,510)